Balar, Agustin .

HRN: 09-17-34  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/07/2024
02/13/2024
IV
2.5 G
Q8
CAP HR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: